Status:
UNKNOWN
Obstructive Sleep Apnea & Covid-19 Outcomes
Lead Sponsor:
Koç University
Collaborating Sponsors:
Koc Healthcare Istanbul American Hospital, Marmara University Hospital
Conditions:
COVID
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Covid-19 infection is an on-going pandemic with worse diagnosis in adults with comorbid conditions such as hypertension and cardiopulmonary diseases. Obstructive sleep apnea (OSA) is common in those c...
Detailed Description
The investigators' primary aim is to address the association between the high probability of having OSA and Covid-19 outcomes within 28 days of the hospitalization. Secondary outcomes will be conduct...
Eligibility Criteria
Inclusion
- Adult patients with Covid 19 diagnosis
- Ability to read and speak
- Signed informed consent.
Exclusion
- Subjects with limited life expectancy due to advanced renal disease or uncontrolled malignancies
- Subjects with alcohol dependency
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04363333
Start Date
April 27 2020
End Date
July 31 2021
Last Update
February 17 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University Hospital
Istanbul, Basibuyuk, Turkey (Türkiye)
2
Koc University
Istanbul, Turkey (Türkiye), TR34010
3
Koc Healthcare Istanbul American Hospital
Istanbul, Turkey (Türkiye)